Similar Items: Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- Determination of Rifapentine and 25-O-desacetyl Rifapentine from 100 µl human breastmilk by LC-MS/MS using protein precipitation and solid phase extraction
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling
- Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
Author: McIlleron, Helen
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects
- Pharmacokinetic-Pharmacogenetic-and-Pharmacodynamic Adherence Relationships in Cohort South African HIV Infected Children on Lopinavir-and Nevirapine-Based Regimens
- Population pharmacokinetic models describing drug-drug interactions and variability in HIV infected South Africans on protease inhibitor-based antiretroviral regimens with and without tuberculosis
- Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach